Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Sharon Worcester

Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.

News

Tumor markers are ‘valuable’ for relapse detection in rare CNS tumors

Author:
Sharon Worcester
Publish date: June 26, 2020

Among evaluable patients, 92% of relapses were detectable by tumor markers.

  • Read More

News

Sequential chemoradiation improves DFS in early-stage cervical cancer

Author:
Sharon Worcester
Publish date: June 22, 2020

The 3-year disease-free survival rate was significantly higher among patients who received sequential chemoradiation than among patients who...

  • Read More

News

Immunotherapy combo improves ORR, PFS in PD-L1+ NSCLC

Author:
Sharon Worcester
Publish date: June 22, 2020

Adding tiragolumab to atezolizumab led to “clinically meaningful” improvements in patients with PD-L1–positive non–small cell lung cancer.

  • Read More

News

No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC

Author:
Sharon Worcester
Publish date: June 10, 2020

Adjuvant gefitinib improved disease-free survival, but not overall survival, when compared with standard chemotherapy.

  • Read More

News

Addressing racism, bias in the American maternal mortality crisis

Author:
Sharon Worcester
Publish date: June 2, 2020

“I think the most important thing you can do is really consider a patient a partner in the care you give them.”

  • Read More

News

Poziotinib provides ‘modest but meaningful’ efficacy in NSCLC subgroup

Author:
Sharon Worcester
Publish date: June 2, 2020

About 15% of patients achieved a response with poziotinib and 65% had a decrease in tumor size.

  • Read More

News

ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer

Author:
Sharon Worcester
Publish date: May 31, 2020

The endocrine-sensitive disease rate was similar whether patients received anastrozole alone, fulvestrant alone, or fulvestrant plus anastrozole...

  • Read More

News

LOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBC

Author:
Sharon Worcester
Publish date: May 28, 2020

Ipatasertib provided a “clinically meaningful,” but not statistically significant, 9-month improvement in median overall survival.

  • Read More

News

Novel penclomedine shows promise for some AYAs with CNS cancers

Author:
Sharon Worcester
Publish date: May 21, 2020

Two patients who responded to the treatment were in their 59th month of survival at last follow-up.

  • Read More

News

Universal CAR-T therapy produces CRs in relapsed/refractory T-ALL

Author:
Sharon Worcester
Publish date: May 19, 2020

All five patients studied achieved a complete response, though one patient had a morphological relapse.

  • Read More

News

MRD surveillance can detect relapse before imaging in early-stage NSCLC

Author:
Sharon Worcester
Publish date: May 13, 2020

Relapse occurred in 9 of 10 patients who were positive for minimal residual disease but had no evidence of relapse on imaging.

  • Read More

News

Vaccine maintenance improves relapse-free survival in BRCA wild-type ovarian cancer

Author:
Sharon Worcester
Publish date: May 6, 2020

Maintenance therapy with gemogenovatucel-T improved relapse-free survival in patients with wild-type BRCA but...

  • Read More

News

The American maternal mortality crisis: The role of racism and bias

Author:
Sharon Worcester
Publish date: May 5, 2020

Not only do health care providers need to face their implicit biases, the health care system needs to change.

  • Read More

News

Adding a blood test to standard screening may improve early cancer detection

Author:
Sharon Worcester
Publish date: May 1, 2020

The blood test detected cancers in seven organs for which no standard screening test is available.

  • Read More

News

EMBRACA shows no overall survival benefit with talazoparib

Author:
Sharon Worcester
Publish date: April 29, 2020

Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast...

  • Read More

Pages

  • « first
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close